The burden of large and rare copy number genetic variants (CNVs) as well as certain specific
CNVs increase the risk of developing schizophrenia. Several cognitive measures are …

Sleep duration has been linked to a wide range of negative health outcomes and to reduced
life expectancy. We present genome-wide association studies of short ( ≤ 5 h) and long ( ≥ …

Background: Dyslipidaemia is an important cardiovascular risk factor for people with severe
mental illness, contributing to premature mortality. The link between antipsychotics and …

Background Antipsychotic-induced weight gain is a contributing factor in the reduced life
expectancy reported amongst people with psychotic disorders. CYP2D6 is a liver enzyme …

CYP2D6 and CYP2C19 enzymes are essential in the metabolism of antidepressants and
antipsychotics. Genetic variation in these genes may increase risk of adverse drug reactions. …

BackgroundChildhood adversity and cannabis use are considered independent risk factors
for psychosis, but whether different patterns of cannabis use may be acting as mediator …

Hyperprolactinemia is a known adverse drug reaction to antipsychotic treatment. Antipsychotic
blood levels are influenced by cytochrome P450 enzymes, primarily CYP2D6. Variation in …

Mismatch negativity (MMN) is a differential electrophysiological response measuring
cortical adaptability to unpredictable stimuli. MMN is consistently attenuated in patients with …

BackgroundWhile cannabis use is a well-established risk factor for psychosis, little is known
about any association between reasons for first using cannabis (RFUC) and later patterns of …

Background and Hypothesis Endophenotypes can help to bridge the gap between psychosis
and its genetic predispositions, but their underlying mechanisms remain largely unknown. …